Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-049627
Filing Date
2025-05-15
Accepted
2025-05-15 17:28:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16732
  Complete submission text file 0001104659-25-049627.txt   18781
Mailing Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131
Business Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Subject) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90268 | Film No.: 25956012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)